In FTD-GRN carriers, circulating PGRN levels are decreased by ∼50% in plasma and CSF (Finch et al., 2009; Ghidoni et al., 2012b; Meeter et al., 2016). The gene discussed is GRN; the disease is frontotemporal dementia.